中文 EN
首页 / 业务领域 / Industry News
[Zhihe Insight] China Innovative Drug Industry Weekly — Week 1 of May 2026
Updated on:2026-10-19
Data sources: PharmCube, PharmaGoGlobal, Sina Finance, NMPA, and other public sources | Compiled by Nanjing Zhihe
Read More>
[R&D Frontier] The Second Half of the ADC Race: From HER2 Red Ocean to “No-Man\\\'s-Land” Targets
Updated on:2026-10-19
In 2025, the number of ADCs in clinical development worldwide surpassed 200, spanning more than 50 targets.Yet the three traditional targets — HER2, TROP2, and Claudin18.2 — have fallen into homogeneous competition.
Read More>
Copyright 2024 Nanjing Chiheal Bio Medicine Technology Co..Ltd All rights reserved.